Literature DB >> 15498463

The human LMX1B gene: transcription unit, promoter, and pathogenic mutations.

Jennifer A Dunston1, Jeanette D Hamlington, Jayshree Zaveri, Elizabeth Sweeney, Julie Sibbring, Catherine Tran, Maria Malbroux, John P O'Neill, Roger Mountford, Iain McIntosh.   

Abstract

LMX1B is a LIM-homeodomain transcription factor required for the normal development of dorsal limb structures, the glomerular basement membrane, the anterior segment of the eye, and dopaminergic and serotonergic neurons. Heterozygous loss-of-function mutations in LMX1B cause nail patella syndrome (NPS). To further understand LMX1B gene regulation and to identify pathogenic mutations within the coding region, a detailed analysis of LMX1B gene structure was undertaken. 5' -RACE and primer extension identified a long 5' -untranslated region of 1.3 kb that contains two upstream open-reading frames (uORFs). Transient transfection assays showed that sequences required for basal promoter activity extend no further than 112 bp upstream. An additional 47 mutations have been identified in the coding region, as well as nine deletions of large portions of the gene, but not in the promoter or highly conserved intronic sequences. The range of mutations and the identification of uORFs suggest further complexity in the regulation of LMX1B expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498463     DOI: 10.1016/j.ygeno.2004.06.002

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  23 in total

1.  LMX1B is essential for the maintenance of differentiated podocytes in adult kidneys.

Authors:  Tillmann Burghardt; Jürgen Kastner; Hani Suleiman; Eric Rivera-Milla; Natalya Stepanova; Claudio Lottaz; Marion Kubitza; Carsten A Böger; Sarah Schmidt; Mathias Gorski; Uwe de Vries; Helga Schmidt; Irmgard Hertting; Jeffrey Kopp; Anne Rascle; Markus Moser; Iris M Heid; Richard Warth; Rainer Spang; Joachim Wegener; Claudia T Mierke; Christoph Englert; Ralph Witzgall
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

2.  Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in Nail-patella syndrome: potential association with LMX1B loss-of-function.

Authors:  Carmen López-Arvizu; Elizabeth P Sparrow; Michael J Strube; Chris Slavin; Caroline DeOleo; Justin James; Julie Hoover-Fong; Iain McIntosh; Elaine Tierney
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-02       Impact factor: 3.568

Review 3.  Serotonergic transcriptional networks and potential importance to mental health.

Authors:  Evan S Deneris; Steven C Wyler
Journal:  Nat Neurosci       Date:  2012-02-26       Impact factor: 24.884

4.  Nail-Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity.

Authors:  Jamal Ghoumid; Florence Petit; Muriel Holder-Espinasse; Anne-Sophie Jourdain; José Guerra; Anne Dieux-Coeslier; Martin Figeac; Nicole Porchet; Sylvie Manouvrier-Hanu; Fabienne Escande
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

5.  Nail-patella syndrome and its association with glaucoma: a review of eight families.

Authors:  Z Mimiwati; D A Mackey; J E Craig; J R Mackinnon; J L Rait; J E Liebelt; R Ayala-Lugo; D Vollrath; J E Richards
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

6.  A variant in LMX1A causes autosomal recessive severe-to-profound hearing impairment.

Authors:  Isabelle Schrauwen; Imen Chakchouk; Khurram Liaqat; Abid Jan; Abdul Nasir; Shabir Hussain; Deborah A Nickerson; Michael J Bamshad; Asmat Ullah; Wasim Ahmad; Suzanne M Leal
Journal:  Hum Genet       Date:  2018-07-03       Impact factor: 4.132

7.  Could the interaction between LMX1B and PAX2 influence the severity of renal symptoms?

Authors:  Susanna Negrisolo; Andrea Carraro; Giulia Fregonese; Elisa Benetti; Franz Schaefer; Marta Alberti; Salvatore Melchionda; Rita Fischetto; Mario Giordano; Luisa Murer
Journal:  Eur J Hum Genet       Date:  2018-07-04       Impact factor: 4.246

Review 8.  Nail-patella syndrome.

Authors:  Ralph Witzgall
Journal:  Pflugers Arch       Date:  2017-07-05       Impact factor: 3.657

9.  Do polymorphisms in transcription factors LMX1A and LMX1B influence the risk for Parkinson's disease?

Authors:  Olle Bergman; Anna Håkansson; Lars Westberg; Andrea Carmine Belin; Olof Sydow; Lars Olson; Björn Holmberg; Laura Fratiglioni; Lars Bäckman; Elias Eriksson; Hans Nissbrandt
Journal:  J Neural Transm (Vienna)       Date:  2009-02-03       Impact factor: 3.575

Review 10.  Kidney disease in nail-patella syndrome.

Authors:  Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.